About Dr. Anadi Pachaury
Dr. Anadi Pachaury is a highly accomplished and leading surgical oncologist in India with over 13 years of extensive experience, particularly in advanced abdominal and pelvic cancer surgeries. He is renowned for his expertise in managing complex and recurrent tumours, utilising state-of-the-art techniques including advanced laparoscopy, robotic surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Trained at the prestigious Tata Memorial Centre, Mumbai, Dr. Pachaury is a proponent of function-preserving surgeries, aiming to maintain patients’ quality of life. His commitment to surgical excellence and patient-centred care establishes him as a top oncologist in India.
OPD Schedule Of Dr. Anadi Pachaury
Consultation Fees Rs. 1100 /-
Manipal Hospitals Dwarka, Delhi
Medical Degrees:
- MCh (Surgical Oncology) – Tata Memorial Centre, Mumbai, India (2019)
- DNB (General Surgery) – National Board of Examinations, New Delhi (2014)
- MS (General Surgery) – Institute of Post Graduate Medical Education & Research (2013)
- MBBS – Sarojini Naidu Medical College, Agra (2008)
Fellowships & Special Training:
- Pool Officer – Delhi State Cancer Institute (2016)
Major Cancer Types Treated:
- Gastrointestinal Cancers (Colorectal, Hepatobiliary-Pancreatic Cancer)
- Peritoneal Surface Malignancies
- Genitourinary Cancers
- Gynaecological Cancers (Advanced Ovarian, Uterine)
- Head & Neck Cancers
- Breast Cancer
Sub-specialties:
- Robotic and Advanced Laparoscopic Cancer Surgeries
- Peritoneal Surface Malignancies (HIPEC/PIPAC/Cytoreductive Surgeries)
- Breast Oncoplasty
- Function Preservation Surgeries (Nerve preserving, Fertility preserving, Continence preserving, Sexual function preserving)
Advanced Procedures Performed:
- Robotic Cancer Surgeries
- Advanced Laparoscopic Cancer Surgeries
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC)
- Cytoreductive Surgeries
- Multi-visceral resections
- Vascular resections
- Pelvic exenteration
- Breast Oncoplasty
Current & Past Hospital Affiliations:
Current Affiliations:
- Associate Director & Unit Head – Surgical Oncology, Max Hospital - Shalimar Bagh
Past Affiliations:
- Senior Consultant – Surgical Oncology, Advanced Laparoscopy, Robotic and HIPEC Surgeon, Manipal Comprehensive Cancer Center, Dwarka, Delhi
- Consultant – Surgical Oncology, Artemis Hospital, Gurugram
- Assistant Professor – Surgical Oncology, Tata Memorial Centre, Mumbai, India
- Assistant Professor (ad-hoc) – Department of Surgical Oncology, Homi Bhabha Cancer Hospital, Tata Memorial Centre, Sangrur, Punjab, India
- Specialist Oncologist – Department of Gastro-intestinal Oncology, Tata Memorial Centre, Mumbai, India
- Resident – Department of Surgical Oncology, Regional Cancer Centre, Medical College and Hospital, Kolkata, India
- Surgical Oncology Registrar – Delhi State Cancer Institute, Delhi, India
- Senior Resident – Surgical Oncology, Cancer Institute, Kolkata, West Bengal, India
- Senior Registrar Surgery – Hindu Rao Hospital · Delhi, India
Academic & Research Roles:
- Actively participates in several research projects.
Key Achievements & Contributions:
- Trained at the prestigious Tata Memorial Centre, Mumbai.
- Gained expertise in advanced laparoscopic, robotic surgical oncology, and HIPEC surgeries at high-volume oncology centres.
- Pioneer in managing advanced and recurrent tumours.
- Strong proponent of function preservation surgeries.
- Credited with numerous publications in esteemed international and national journals.
Published Papers in Medical Journals:
- “Invasive primary endometrial squamous cell carcinoma secondary to chronic inflammation by retained IUCD, a non HPV related pathway: A case report”, Authoreo (2022).
- “Outcomes of gastric and small intestinal GISTs (Gastrointestinal Stromal Tumors) after curative resection and aggressive re-resection of recurrence in Imotinib era: A propensity matched analysis“, Pachaury A, Bhandare M, Rohila J, et al. (2021).
- “Pathological N3 Stage (pN3/ypN3) Gastric Cancer Outcomes, Prognostic Factors and Pattern of Recurrences after Curative Treatment“, Annals of Surgical Oncology (2020).
- “Evolution of Robotic Surgery in a Colorectal Cancer Unit in India”, Indian Journal of Surgical Oncology (2020).
- “Gastric adenocarcinoma masquerading as oral cavity malignancy”, International Journal of Case Reports and Short Reviews.
- “Comparative analysis of short and long term outcomes following prone versus supine extra-levato abdominoperineal resection (ELAPR) for locally advanced rectal cancer”, Journal of Colorectal Diseases (2019).
- Oral presentation on “Use of Oncoplastic techniques in neoadjuvant non responder patients of carcinoma breast”, ASICON (2015).
- Poster Presentation on “Giant biliary cystic neoplasm of Liver series of 7 patient”, ICC (2013).
- Oral presentation on “Hydatid cyst of liver presenting in an atypical manner”, SASICON (2011).
- “A Comparative study between longitudinal Pancreatico-jejunostomy v/s lateral pancreatico-gastrostomy as a drainage procedure for pain relief in chronic Pancreatitis done in a tertiary referral center of Eastern India”, Indian Journal of Surgery (2012).
- “Demographic and clinico-pathological profile of Carcinoma Stomach in tertiary referral center of Eastern India”, Al Ameen Journal of Medical Sciences (2012).
- “Epidemiological clinico-pathological profile and management of colorectal carcinoma in tertiary referral center of Eastern India”, Journal of Krishna Institute of Medical Sciences University (2012).
- “Invasive primary endometrial squamous cell carcinoma secondary to chronic inflammation by retained IUCD, a non HPV related pathway. : a case report”, Preprint (Mar 2022).
- “Assessment of Quality of life in patients underwent post ppylorus-preserving pancreaticoduodenectomy (PPPD) with pancreaticogastrostomy”, Article (Feb 2022).
- “ASO Visual Abstract: Pathologic N3 Stage (pN3/ypN3) Gastric Cancer—Outcomes, Prognostic Factors, and Pattern of Recurrences after Curative Treatment”, Article (Aug 2021).
- “ASO Authors Reflection: N3 Stage Gastric Cancer Needs Treatment Intensification”, Article (Jul 2021).
- “Pathological N3 Stage (pN3/ypN3) Gastric Cancer: Outcomes, Prognostic Factors and Pattern of Recurrences After Curative Treatment”, Article (Jul 2021).
- “Outcomes of gastric and small Intestinal GISTs (Gastrointestinal Stromal Tumors) after curative resection and aggressive re-resection of recurrence; in Imatinib era: A propensity matched analysis.”, Article (Feb 2021).
- “Gastric Adenocarcinoma Masquerading as oral Cavity Malignancy - SCIRES Literature -Volume 6 Issue 5 -www.scireslit.com”, Article (Jun 2020).
- “Giant Biliary cystic neoplasms of liver: a series of 7 patients”, Conference Paper (Nov 2013).
Notable Cases Handled:
- Specialised in managing advanced and recurrent tumours, routinely performing supra-major surgeries including multi-visceral resections, vascular resections, pelvic exenteration, cytoreductive surgery, and HIPEC.
Patient Testimonials:
"I was so scared when I received my diagnosis, but Dr. Pachaury's calm demeanour and clear explanation of my treatment options put me at ease. The robotic surgery he performed was incredibly successful, and my recovery was much faster than I anticipated. I'm truly grateful for his expertise and compassionate care." - Anjali Sharma
"Facing a complex cancer diagnosis, I sought out the best, and Dr. Pachaury exceeded all expectations. His surgical skill in my HIPEC procedure was remarkable, and his team provided excellent post-operative care. I felt supported and confident throughout my entire journey." - Rajeev Kumar
"Dr. Pachaury is not just an excellent surgeon but also a wonderful human being. He took the time to answer all my questions and fears about my breast cancer surgery. The outcome was fantastic, and I appreciate his dedication to both the medical and emotional aspects of my recovery." - Priya Singh
Patient-Centred Care: Dr. Anadi Pachaury's philosophy is deeply rooted in patient-centred care, particularly for those battling advanced and recurrent cancers. He is a strong advocate for function preservation surgeries, meticulously planning procedures to maintain nerve function, fertility, continence, and sexual health whenever surgically feasible. His approach ensures that patients not only receive the most effective treatment but also retain the highest possible quality of life post-surgery.
Technology & Innovation: Dr. Pachaury is at the forefront of surgical innovation, extensively utilising robotic and advanced laparoscopic techniques for cancer surgeries. This commitment to cutting-edge technology allows for greater precision, smaller incisions, reduced blood loss, faster recovery times, and improved patient outcomes. His expertise in procedures like HIPEC and PIPAC for peritoneal surface malignancies demonstrates his dedication to employing the latest advancements in oncology.
Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
Robotic Cancer Surgery | 4,00,000 - 8,00,000 | 4,800 - 9,600 |
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) | 8,00,000 - 15,00,000 | 9,600 - 18,000 |
Advanced Laparoscopic Cancer Surgery | 3,00,000 - 7,00,000 | 3,600 - 8,400 |
Breast Cancer Surgery (Oncoplasty) | 2,50,000 - 5,00,000 | 3,000 - 6,000 |
Gastrointestinal Cancer Surgery | 3,50,000 - 9,00,000 | 4,200 - 10,800 |
For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.
Language Support: The Cancer Rounds team typically offers comprehensive support for international patients, including multilingual assistance to ensure clear communication throughout the treatment journey.
Visa & Travel Assistance: The Cancer Rounds team provides dedicated assistance with visa applications, travel arrangements, airport transfers, and comfortable accommodation options for international patients and their families.
Pre-treatment Virtual Consultations: To facilitate initial assessments and provide peace of mind, Dr. Anadi Pachaury may offer pre-treatment virtual consultations through the Cancer Rounds platform, allowing for a review of medical records and second opinions before patients travel to India.